Table 4.

Regression models for early predictors of PTS per stratum

Coefficient estimate (95% CI)P
CVC-related thrombosis stratum   
 Age at DVT diagnosis (for every y) 0.6 (0.1-1.2) .02 
 N of d on therapeutic anticoagulation in first month post-DVT 0.0 (−0.1 to 0.1) .44 
 Presence of symptoms 0.3 (−2.5 to 3.1) .84 
 Time from DVT diagnosis to PTS assessment (for every y) 0.9 (0.4-1.3) <.001 
 DVT burden (for every point)* 0.7 (0.1-1.4) .05 
Non–CVC-related thrombosis stratum   
 Age at DVT diagnosis (for every y) 1.7 (1.0-2.4) <.001 
 N of d on therapeutic anticoagulation in first month post-DVT −0.2 (−0.6 to 0.2) .26 
 Time from DVT diagnosis to PTS assessment (for every y) 0.9 (−1.2 to 2.9) .41 
 DVT burden (for every point)* 3.6 (−1.9 to 9.1) .21 
Coefficient estimate (95% CI)P
CVC-related thrombosis stratum   
 Age at DVT diagnosis (for every y) 0.6 (0.1-1.2) .02 
 N of d on therapeutic anticoagulation in first month post-DVT 0.0 (−0.1 to 0.1) .44 
 Presence of symptoms 0.3 (−2.5 to 3.1) .84 
 Time from DVT diagnosis to PTS assessment (for every y) 0.9 (0.4-1.3) <.001 
 DVT burden (for every point)* 0.7 (0.1-1.4) .05 
Non–CVC-related thrombosis stratum   
 Age at DVT diagnosis (for every y) 1.7 (1.0-2.4) <.001 
 N of d on therapeutic anticoagulation in first month post-DVT −0.2 (−0.6 to 0.2) .26 
 Time from DVT diagnosis to PTS assessment (for every y) 0.9 (−1.2 to 2.9) .41 
 DVT burden (for every point)* 3.6 (−1.9 to 9.1) .21 
*

DVT burden score (see data supplement for details): occlusive DVT (yes = 2) + iliofemoral DVT (yes = 1) + n of affected venous segments (maximum score of 1 if entire UE or LE venous territory affected). Maximum score, 5 points.

Close Modal

or Create an Account

Close Modal
Close Modal